156 related articles for article (PubMed ID: 17341424)
1. Metabolic correction in oligodendrocytes derived from metachromatic leukodystrophy mouse model by using encapsulated recombinant myoblasts.
Consiglio A; Martino S; Dolcetta D; Cusella G; Conese M; Marchesini S; Benaglia G; Wrabetz L; Orlacchio A; Déglon N; Aebischer P; Severini GM; Bordignon C
J Neurol Sci; 2007 Apr; 255(1-2):7-16. PubMed ID: 17341424
[TBL] [Abstract][Full Text] [Related]
2. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
[TBL] [Abstract][Full Text] [Related]
3. In vitro correction of ARSA deficiency in human skin fibroblasts from metachromatic leukodystrophy patients after treatment with microencapsulated recombinant cells.
Lagranha VL; Baldo G; de Carvalho TG; Burin M; Saraiva-Pereira ML; Matte U; Giugliani R
Metab Brain Dis; 2008 Dec; 23(4):469-84. PubMed ID: 18797988
[TBL] [Abstract][Full Text] [Related]
4. Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice.
Piguet F; Sondhi D; Piraud M; Fouquet F; Hackett NR; Ahouansou O; Vanier MT; Bieche I; Aubourg P; Crystal RG; Cartier N; Sevin C
Hum Gene Ther; 2012 Aug; 23(8):903-14. PubMed ID: 22642214
[TBL] [Abstract][Full Text] [Related]
5. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
Meneghini V; Frati G; Sala D; De Cicco S; Luciani M; Cavazzin C; Paulis M; Mentzen W; Morena F; Giannelli S; Sanvito F; Villa A; Bulfone A; Broccoli V; Martino S; Gritti A
Stem Cells Transl Med; 2017 Feb; 6(2):352-368. PubMed ID: 28191778
[TBL] [Abstract][Full Text] [Related]
6. Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy.
Givogri MI; Galbiati F; Fasano S; Amadio S; Perani L; Superchi D; Morana P; Del Carro U; Marchesini S; Brambilla R; Wrabetz L; Bongarzone E
J Neurosci; 2006 Mar; 26(12):3109-19. PubMed ID: 16554462
[TBL] [Abstract][Full Text] [Related]
7. Single Systemic Administration of a Gene Therapy Leading to Disease Treatment in Metachromatic Leukodystrophy
St Martin T; Seabrook TA; Gall K; Newman J; Avila N; Hayes A; Kivaa M; Lotterhand J; Mercaldi M; Patel K; Rivas IJ; Woodcock S; Wright TL; Seymour AB; Francone OL; Gingras J
J Neurosci; 2023 May; 43(19):3567-3581. PubMed ID: 36977578
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
[TBL] [Abstract][Full Text] [Related]
9. Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer.
Sevin C; Verot L; Benraiss A; Van Dam D; Bonnin D; Nagels G; Fouquet F; Gieselmann V; Vanier MT; De Deyn PP; Aubourg P; Cartier N
Gene Ther; 2007 Mar; 14(5):405-14. PubMed ID: 17093507
[TBL] [Abstract][Full Text] [Related]
10. Transduced fibroblasts and metachromatic leukodystrophy lymphocytes transfer arylsulfatase A to myelinating glia and deficient cells in vitro.
Sangalli A; Taveggia C; Salviati A; Wrabetz L; Bordignon C; Severini GM
Hum Gene Ther; 1998 Sep; 9(14):2111-9. PubMed ID: 9759937
[TBL] [Abstract][Full Text] [Related]
11. AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase a efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy.
Kurai T; Hisayasu S; Kitagawa R; Migita M; Suzuki H; Hirai Y; Shimada T
Mol Ther; 2007 Jan; 15(1):38-43. PubMed ID: 17164773
[TBL] [Abstract][Full Text] [Related]
12. Safety of arylsulfatase A overexpression for gene therapy of metachromatic leukodystrophy.
Capotondo A; Cesani M; Pepe S; Fasano S; Gregori S; Tononi L; Venneri MA; Brambilla R; Quattrini A; Ballabio A; Cosma MP; Naldini L; Biffi A
Hum Gene Ther; 2007 Sep; 18(9):821-36. PubMed ID: 17845130
[TBL] [Abstract][Full Text] [Related]
13. Axons mediate the distribution of arylsulfatase A within the mouse hippocampus upon gene delivery.
Luca T; Givogri MI; Perani L; Galbiati F; Follenzi A; Naldini L; Bongarzone ER
Mol Ther; 2005 Oct; 12(4):669-79. PubMed ID: 16087406
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and safety of multiple routes of direct CNS administration of adeno-associated virus gene transfer vector serotype rh.10 expressing the human arylsulfatase A cDNA to nonhuman primates.
Rosenberg JB; Sondhi D; Rubin DG; Monette S; Chen A; Cram S; De BP; Kaminsky SM; Sevin C; Aubourg P; Crystal RG
Hum Gene Ther Clin Dev; 2014 Sep; 25(3):164-77. PubMed ID: 25144894
[TBL] [Abstract][Full Text] [Related]
15. Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A.
Miyake N; Miyake K; Sakai A; Yamamoto M; Suzuki H; Shimada T
Sci Rep; 2021 Oct; 11(1):20513. PubMed ID: 34654893
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary redesign of the lysosomal enzyme arylsulfatase A increases efficacy of enzyme replacement therapy for metachromatic leukodystrophy.
Simonis H; Yaghootfam C; Sylvester M; Gieselmann V; Matzner U
Hum Mol Genet; 2019 Jun; 28(11):1810-1821. PubMed ID: 30657900
[TBL] [Abstract][Full Text] [Related]
17. High residual arylsulfatase A (ARSA) activity in a patient with late-infantile metachromatic leukodystrophy.
Kreysing J; Bohne W; Bösenberg C; Marchesini S; Turpin JC; Baumann N; von Figura K; Gieselmann V
Am J Hum Genet; 1993 Aug; 53(2):339-46. PubMed ID: 8101038
[TBL] [Abstract][Full Text] [Related]
18. Multipotential neural precursors transplanted into the metachromatic leukodystrophy brain fail to generate oligodendrocytes but contribute to limit brain dysfunction.
Givogri MI; Bottai D; Zhu HL; Fasano S; Lamorte G; Brambilla R; Vescovi A; Wrabetz L; Bongarzone E
Dev Neurosci; 2008; 30(5):340-57. PubMed ID: 18667806
[TBL] [Abstract][Full Text] [Related]
19. Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates.
Zerah M; Piguet F; Colle MA; Raoul S; Deschamps JY; Deniaud J; Gautier B; Toulgoat F; Bieche I; Laurendeau I; Sondhi D; Souweidane MM; Cartier-Lacave N; Moullier P; Crystal RG; Roujeau T; Sevin C; Aubourg P
Hum Gene Ther Clin Dev; 2015 Jun; 26(2):113-24. PubMed ID: 25758611
[TBL] [Abstract][Full Text] [Related]
20. Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy.
Sevin C; Benraiss A; Van Dam D; Bonnin D; Nagels G; Verot L; Laurendeau I; Vidaud M; Gieselmann V; Vanier M; De Deyn PP; Aubourg P; Cartier N
Hum Mol Genet; 2006 Jan; 15(1):53-64. PubMed ID: 16311251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
